Dr. Oluwoye, Dr. McDonell, and Dr. Dyck are with Washington State University, Spokane. Dr. Oluwoye and Dr. McDonell are with the Initiative for Research and Education to Advance Community Health and the Department of Medical Education and Clinical Sciences, Elson S. Floyd College of Medicine, and Dr. Dyck is with the Department of Psychology. Mr. Stiles, Dr. Monroe-DeVita, Dr. Chwastiak, and Dr. McClellan are with the Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle. Dr. Cabassa is with the George Warren Brown School of Social Work, Washington University in St. Louis, St. Louis.
Psychiatr Serv. 2018 Nov 1;69(11):1138-1145. doi: 10.1176/appi.ps.201800067. Epub 2018 Aug 28.
This study examined racial and ethnic differences in treatment outcomes among participants in a randomized controlled trial of an intervention for first-episode psychosis called NAVIGATE.
Secondary data analyses were conducted for participants randomly assigned to usual community care (N=181) and NAVIGATE (N=223). Generalized estimating equations assessed whether race and ethnicity were associated with psychiatric symptoms and service use (medication management, family psychoeducation, and individual therapy) over a 24-month treatment period, accounting for baseline symptoms, duration of untreated psychosis, and insurance status.
Among persons in usual community care, non-Hispanic blacks scored significantly higher throughout treatment on measures of positive symptoms (β=2.15, p=.010), disorganized thoughts (β=1.15, p=.033), and uncontrolled hostility (β=.74, p=.027), compared with non-Hispanic whites, and non-Hispanic blacks were less likely than non-Hispanic whites to receive individual therapy (OR=.45, p=.001). Families of Hispanic participants in usual community care were less likely than non-Hispanic white families to receive family psychoeducation (OR=.20, p=.01). For NAVIGATE participants, race and ethnicity were not associated with differences in psychiatric symptoms over time; families of non-Hispanic black participants were less likely than those of non-Hispanic white participants to receive family psychoeducation (OR=.53, p=.009). Hispanic participants in NAVIGATE were more likely than non-Hispanic white participants to receive medication management (OR=2.93, p=.001).
In usual community care, non-Hispanic blacks scored higher on measures of psychiatric symptoms and were less likely to receive important services, compared with non-Hispanic whites. In NAVIGATE, racial and ethnic differences in psychiatric symptoms were not evident, although non-Hispanic blacks were less likely than non-Hispanic whites to receive family psychoeducation.
本研究考察了参与一项针对首发精神病的干预措施(称为 NAVIGATE)的随机对照试验中参与者的治疗结果的种族和民族差异。
对随机分配至常规社区护理(N=181)和 NAVIGATE(N=223)的参与者进行了二次数据分析。广义估计方程评估了种族和民族是否与 24 个月治疗期间的精神症状和服务使用(药物管理、家庭心理教育和个体治疗)相关,考虑了基线症状、未治疗精神病的持续时间和保险状况。
在常规社区护理中,与非西班牙裔白人相比,非西班牙裔黑人在整个治疗过程中在阳性症状(β=2.15,p=.010)、思维紊乱(β=1.15,p=.033)和不受控制的敌意(β=.74,p=.027)方面的得分显着更高,而非西班牙裔黑人接受个体治疗的可能性也低于非西班牙裔白人(OR=.45,p=.001)。常规社区护理中的西班牙裔参与者的家庭接受家庭心理教育的可能性也低于非西班牙裔白人家庭(OR=.20,p=.01)。对于 NAVIGATE 参与者,种族和民族与随时间变化的精神症状差异无关;与非西班牙裔白人参与者相比,非西班牙裔黑人参与者的家庭接受家庭心理教育的可能性较低(OR=.53,p=.009)。接受 NAVIGATE 治疗的西班牙裔参与者接受药物管理的可能性也高于非西班牙裔白人参与者(OR=2.93,p=.001)。
在常规社区护理中,与非西班牙裔白人相比,非西班牙裔黑人的精神症状评分更高,并且接受重要服务的可能性更低。在 NAVIGATE 中,精神症状方面的种族和民族差异并不明显,尽管与非西班牙裔白人相比,非西班牙裔黑人接受家庭心理教育的可能性较低。